Osaic Holdings’s Allena Pharmaceuticals ALNA Stock Holding History

Osaic Holdings’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33,000	Closed	-$6K	–	7740
2022 Q2	$6K	Hold	33,000	–	–	﹤0.01%	6439
2022 Q1	$7K	Buy	33,000 +10,000	+43%	+$4.14K	﹤0.01%	6366
2021 Q4	$14K	Hold	23,000	–	–	﹤0.01%	6071
2021 Q3	$21K	Hold	23,000	–	–	﹤0.01%	5754
2021 Q2	$30K	Hold	23,000	–	–	﹤0.01%	5409
2021 Q1	$32K	Buy	23,000 +5,000	+28%	+$8.33K	﹤0.01%	5202
2020 Q4	$23K	Hold	18,000	–	–	﹤0.01%	5085
2020 Q3	$27K	Sell	18,000 -2,000	-10%	-$2.81K	﹤0.01%	4745
2020 Q2	$32K	Buy	20,000 +9,000	+82%	+$15.1K	﹤0.01%	4511
2020 Q1	$11K	Buy	+11,000	New	+$22K	﹤0.01%	4973

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Osaic Holdings's ALNA Position: Q3 2022 in Review

Osaic Holdings sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 33,000 shares — an estimated $6K sold.

Osaic Holdings first reported a position in ALNA in Q1 2020 and held it in 10 quarters. The position peaked at $32K in Q1 2021. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Osaic Holdings reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Osaic Holdings sold 33,000 Allena Pharmaceuticals shares in Q3 2022, an estimated $6K.
Osaic Holdings first reported a position in Allena Pharmaceuticals in Q1 2020 and held it in 10 quarters.
Osaic Holdings's Allena Pharmaceuticals position peaked at $32K in Q1 2021.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Osaic Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.